Regulations for Registration of Medicinal Products Article 11
The Manufacturing and Control Standard mentioned in this Chapter refers to the Manufacturing and Control Standard in compliance with Part 2 of Good Manufacturing Practice Regulations (Good Manufacturing Practices for Pharmaceuticals), including data of the actual amount of material used in batch records.The manufacturing records mentioned in this Chapter refer to the manufacturing records of the same lot as the samples submitted for tests. In the case where the data of the same lot is not available or the products are exempt from testing, the applicant can submit the manufacturing records of any batch produced within two years from the date of application or a representative batch.The representative batch is a batch of drug product that is manufactured using the same formulation, manufacturing process, and in-process controls, etc. as the application for drug registration or post-approval changes. The applicant should provide proof of the unaffected product quality for the change of the manufacturing process and in-process controls, and should be approved by the central health competent authority.
中文原文 藥品查驗登記審查準則第11條
本章所稱製造管制標準書,指符合藥物優良製造準則第二編規定(以下簡稱藥品優良製造規範)之製造管制標準書。
本章所稱批次製造紀錄,指與送驗樣品同一批之批次製造紀錄。
但如無法檢送同一批次或無須送驗者,得以查驗登記或變更登記申請日前二年內或具代表性之任一批批次製造紀錄替代。
前項所稱之具代表性,指處方、製程、製程管制等均與查驗登記或變更登記申請案相同,或製程、製程管制之改變,經提出不影響品質之證明獲中央衛生主管機關同意者。
本章所稱批次製造紀錄,指與送驗樣品同一批之批次製造紀錄。
但如無法檢送同一批次或無須送驗者,得以查驗登記或變更登記申請日前二年內或具代表性之任一批批次製造紀錄替代。
前項所稱之具代表性,指處方、製程、製程管制等均與查驗登記或變更登記申請案相同,或製程、製程管制之改變,經提出不影響品質之證明獲中央衛生主管機關同意者。